ATG5 and melanoma: Importantly, single-copy loss of ATG5 has been identified as a distinctive feature of advanced melanomas, regardless of the mutational status of melanoma associated-oncogenes (e.g., BRAF, RAS), and associated with poor overall patient survival (Figure 1C) (65).